Hospital Admin Medical News about biopharmaceutical

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Biologics dont need long market exclusivity, FTC says
American Medical News , 06/30/09

Trapp D - A recent Federal Trade Commission report asserting that original biopharmaceutical drug manufacturers do not need lengthy exclusive marketing periods to maintain innovation has not driven supporters from a bill that would extend such protection.

<< Previous
Dont shortchange specialists to fund care model

Next >>
Mental health policy in South Africa: development process and...

Nabi Biopharmaceuticals to Hold Conference Call
Nabi Biopharmaceuticals, 11/17/09 Relevance Score: 87%

Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
Bristol Myers-Squibb Company, 11/11/09 Relevance Score: 84%

Nabi Biopharmaceuticals Participates in NicVAX(R) Phase IIb Study
Nabi Biopharmaceuticals, 10/29/09 Relevance Score: 84%

Nabi Biopharmaceuticals to Announce Third Quarter Financial Results on November 2009
Nabi Biopharmaceuticals, 10/28/09 Relevance Score: 84%

Sanofi-aventis to acquire FOVEA, a French biopharmaceutical ophthalmology company
Sanofi-aventis, 10/02/09 Relevance Score: 84%